How many drugs treat Nocturnal enuresis?

Drug Landscape tracks 3 marketed treatments for Nocturnal enuresis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/nocturnal-enuresis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Nocturnal enuresis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nocturnal enuresis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Nocturnal enuresis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Ddavp	DESMOPRESSIN	Ferring Pharms Inc	Factor VIII Activator	Vasopressin V1b receptor	1978-01-01
Minirin	Minirin	Hormozgan University of Medical Sciences		Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V1b receptor
Argipressin	Argipressin	Kristina Svennerholm		Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V1b receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Nocturnal enuresis
Ferring Pharms Inc · 1 drug in Nocturnal enuresis
Hormozgan University of Medical Sciences · 1 drug in Nocturnal enuresis
Kristina Svennerholm · 1 drug in Nocturnal enuresis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Nocturnal enuresis:

Cite this brief

Drug Landscape (2026). Nocturnal enuresis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/nocturnal-enuresis. Accessed 2026-06-10.

Nocturnal enuresis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing